These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 37766614)
1. The potential clinical value of pairing procalcitonin and lung ultrasonography to guide antibiotic therapy in patients with community-acquired pneumonia: a narrative review. Bessat C; Boillat-Blanco N; Albrich WC Expert Rev Respir Med; 2023; 17(10):919-927. PubMed ID: 37766614 [TBL] [Abstract][Full Text] [Related]
2. Procalcitonin and lung ultrasonography point-of-care testing to decide on antibiotic prescription in patients with lower respiratory tract infection in primary care: protocol of a pragmatic cluster randomized trial. Lhopitallier L; Kronenberg A; Meuwly JY; Locatelli I; Dubois J; Marti J; Mueller Y; Senn N; D'Acremont V; Boillat-Blanco N BMC Pulm Med; 2019 Aug; 19(1):143. PubMed ID: 31387559 [TBL] [Abstract][Full Text] [Related]
3. PLUS-IS-LESS project: Procalcitonin and Lung UltraSonography-based antibiotherapy in patients with Lower rESpiratory tract infection in Swiss Emergency Departments: study protocol for a pragmatic stepped-wedge cluster-randomized trial. Bessat C; Bingisser R; Schwendinger M; Bulaty T; Fournier Y; Della Santa V; Pfeil M; Schwab D; Leuppi JD; Geigy N; Steuer S; Roos F; Christ M; Sirova A; Espejo T; Riedel H; Atzl A; Napieralski F; Marti J; Cisco G; Foley RA; Schindler M; Hartley MA; Fayet A; Garcia E; Locatelli I; Albrich WC; Hugli O; Boillat-Blanco N; Trials; 2024 Jan; 25(1):86. PubMed ID: 38273319 [TBL] [Abstract][Full Text] [Related]
4. Lung ultrasound and procalcitonin, improving antibiotic management and avoiding radiation exposure in pediatric critical patients with bacterial pneumonia: a randomized clinical trial. Guitart C; Bobillo-Perez S; Rodríguez-Fanjul J; Carrasco JL; Brotons P; López-Ramos MG; Cambra FJ; Balaguer M; Jordan I Eur J Med Res; 2024 Apr; 29(1):222. PubMed ID: 38581075 [TBL] [Abstract][Full Text] [Related]
5. An algorithm combining procalcitonin and lung ultrasound improves the diagnosis of bacterial pneumonia in critically ill children: The PROLUSP study, a randomized clinical trial. Guitart C; Rodríguez-Fanjul J; Bobillo-Perez S; Carrasco JL; Inarejos Clemente EJ; Cambra FJ; Balaguer M; Jordan I Pediatr Pulmonol; 2022 Mar; 57(3):711-723. PubMed ID: 34921717 [TBL] [Abstract][Full Text] [Related]
6. Procalcitonin and lung ultrasound algorithm to diagnose severe pneumonia in critical paediatric patients (PROLUSP study). A randomised clinical trial. Rodríguez-Fanjul J; Guitart C; Bobillo-Perez S; Balaguer M; Jordan I Respir Res; 2020 Oct; 21(1):255. PubMed ID: 33032612 [TBL] [Abstract][Full Text] [Related]
7. An update on the pharmacotherapeutic management of lower respiratory tract infections. Cazzola M; Rogliani P; Aliberti S; Blasi F; Matera MG Expert Opin Pharmacother; 2017 Jul; 18(10):973-988. PubMed ID: 28480770 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic accuracy of lung ultrasonography combined with procalcitonin for the diagnosis of pneumonia: a pilot study. Nazerian P; Cerini G; Vanni S; Gigli C; Zanobetti M; Bartolucci M; Grifoni S; Volpicelli G Crit Ultrasound J; 2016 Dec; 8(1):17. PubMed ID: 27830508 [TBL] [Abstract][Full Text] [Related]
9. [Value of serum procalcitonin for the guidance of antibiotic therapy in children with lower respiratory tract infection]. Dai BQ; Yuan XT; Liu JM Zhongguo Dang Dai Er Ke Za Zhi; 2015 Dec; 17(12):1292-6. PubMed ID: 26695667 [TBL] [Abstract][Full Text] [Related]
10. Impact of Procalcitonin Guidance with an Educational Program on Management of Adults Hospitalized with Pneumonia. Walsh TL; DiSilvio BE; Hammer C; Beg M; Vishwanathan S; Speredelozzi D; Moffa MA; Hu K; Abdulmassih R; Makadia JT; Sandhu R; Naddour M; Chan-Tompkins NH; Trienski TL; Watson C; Obringer TJ; Kuzyck J; Bremmer DN Am J Med; 2018 Feb; 131(2):201.e1-201.e8. PubMed ID: 28947168 [TBL] [Abstract][Full Text] [Related]
11. Procalcitonin to Distinguish Viral From Bacterial Pneumonia: A Systematic Review and Meta-analysis. Kamat IS; Ramachandran V; Eswaran H; Guffey D; Musher DM Clin Infect Dis; 2020 Jan; 70(3):538-542. PubMed ID: 31241140 [TBL] [Abstract][Full Text] [Related]
12. Lung ultrasonography to diagnose community-acquired pneumonia in children. Principi N; Esposito A; Giannitto C; Esposito S BMC Pulm Med; 2017 Dec; 17(1):212. PubMed ID: 29258484 [TBL] [Abstract][Full Text] [Related]
13. Procalcitonin guidance for reduction of antibiotic use in low-risk outpatients with community-acquired pneumonia. Long W; Deng X; Zhang Y; Lu G; Xie J; Tang J Respirology; 2011 Jul; 16(5):819-24. PubMed ID: 21507143 [TBL] [Abstract][Full Text] [Related]
14. The Use of Lung Ultrasound to Monitor the Antibiotic Response of Community-Acquired Pneumonia in Children: A Preliminary Hypothesis. Buonsenso D; Brancato F; Valentini P; Curatola A; Supino M; Musolino AM J Ultrasound Med; 2020 Apr; 39(4):817-826. PubMed ID: 31633230 [TBL] [Abstract][Full Text] [Related]
15. Procalcitonin-guided antibiotic therapy in patients with fever in a general emergency department population: a multicentre non-inferiority randomized clinical trial (HiTEMP study). van der Does Y; Limper M; Jie KE; Schuit SCE; Jansen H; Pernot N; van Rosmalen J; Poley MJ; Ramakers C; Patka P; van Gorp ECM; Rood PPM Clin Microbiol Infect; 2018 Dec; 24(12):1282-1289. PubMed ID: 29870855 [TBL] [Abstract][Full Text] [Related]
16. Comparison of procalcitonin testing to a targeted audit-and-feedback strategy on prescribed durations of therapy for community-acquired pneumonia. Clark LT; Beuschel TS; Buss PM; Jameson AP; Dumkow LE Diagn Microbiol Infect Dis; 2021 Jan; 99(1):115202. PubMed ID: 33007583 [TBL] [Abstract][Full Text] [Related]
17. A Collaborative Approach to Improve Consistent Use of Procalcitonin in Lower Respiratory Tract Infections. Levine AR; Riggott R; Vulaj K; Falcetti TR; Ali S; Singh G Ann Pharmacother; 2018 Jun; 52(6):538-545. PubMed ID: 29322872 [TBL] [Abstract][Full Text] [Related]
18. Point-of-care lung ultrasound for the assessment of pneumonia: a narrative review in the COVID-19 era. Kameda T; Mizuma Y; Taniguchi H; Fujita M; Taniguchi N J Med Ultrason (2001); 2021 Jan; 48(1):31-43. PubMed ID: 33438132 [TBL] [Abstract][Full Text] [Related]
19. Procalcitonin-Guided Antibiotic Discontinuation Might Shorten the Duration of Antibiotic Treatment Without Increasing Pneumonia Recurrence. Akagi T; Nagata N; Wakamatsu K; Harada T; Miyazaki H; Takeda S; Ushijima S; Aoyama T; Yoshida Y; Yatsugi H; Wada K; Ueda Y; Fujita M; Watanabe K Am J Med Sci; 2019 Jul; 358(1):33-44. PubMed ID: 31084909 [TBL] [Abstract][Full Text] [Related]
20. Biological markers to determine eligibility in trials for community-acquired pneumonia: a focus on procalcitonin. Niederman MS Clin Infect Dis; 2008 Dec; 47 Suppl 3():S127-32. PubMed ID: 18986278 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]